IDEAS home Printed from https://ideas.repec.org/a/eme/srjpps/srj-05-2025-0499.html

Governance and management drivers of ESG-washing in the pharmaceutical industry: an empirical analysis

Author

Listed:
  • Adriana Silva
  • Catarina Alexandra Neves Proença
  • Diana Dantas
  • Maria Elisabete Neves

Abstract

PurposeThis study aims to identify the determinants of ESG-washing in the pharmaceutical sector, focusing on governance and management factors that influence companies’ deceptive sustainability practices.Design/methodology/approachA sample of 140 global pharmaceutical companies listed between 2016 and 2022 was analysed using the generalized method of moments system methodology to test the hypotheses related to governance and management variables affecting ESG-washing practices.FindingsThe results reveal that ESG-washing is present in the pharmaceutical sector, with certain governance factors playing a significant role. Specifically, larger board sizes, female representation on boards and ISO 14001 certification are associated with an increase in ESG-washing practices. Conversely, the presence of experienced directors and higher investments in research and development are found to reduce ESG-washing tendencies.Practical implicationsStricter regulations and governance reforms are needed to prevent ESG-washing in the pharmaceutical sector. Investors and consumers should critically assess corporate sustainability claims.Social implicationsESG-washing undermines public trust, delays environmental interventions and weakens workplace ethics. Regulatory and societal pressure will increase, demanding authentic sustainability efforts. Persistent ESG-washing may damage the pharmaceutical industry’s reputation, leading to stricter regulations and declining consumer confidence.Originality/valueThis study provides a novel contribution to the literature by examining ESG-washing determinants in the pharmaceutical sector. This area has received limited attention. The findings offer critical insights for regulators, investors, managers and civil society, aiding the development of effective strategies to mitigate ESG-washing and promote genuine sustainability efforts in the industry.

Suggested Citation

  • Adriana Silva & Catarina Alexandra Neves Proença & Diana Dantas & Maria Elisabete Neves, 2026. "Governance and management drivers of ESG-washing in the pharmaceutical industry: an empirical analysis," Social Responsibility Journal, Emerald Group Publishing Limited, vol. 22(5), pages 1159-1177, March.
  • Handle: RePEc:eme:srjpps:srj-05-2025-0499
    DOI: 10.1108/SRJ-05-2025-0499
    as

    Download full text from publisher

    File URL: https://www.emerald.com/srj/article/22/5/1159/1345942/Governance-and-management-drivers-of-ESG-washing
    Download Restriction: no

    File URL: https://www.emerald.com/srj/article-pdf/22/5/1159/11294922/srj-05-2025-0499en.pdf
    Download Restriction: no

    File URL: https://libkey.io/10.1108/SRJ-05-2025-0499?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eme:srjpps:srj-05-2025-0499. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Emerald Support (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.